Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

HBIO holding history

Harvard Bioscience Inc in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

HBIO overviewAll 13F holders of HBIOFull Q2 2026 holdings

Shares (Q2 2026)
17,581
Value
$108.1K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of HBIO by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202617,581$108.1K<0.1%+9,176+109.2%AddedHolders
Q1 20268,405$40.9K<0.1%+6,284+296.2%AddedConverted for a 1-for-10 splitHolders
Q4 202521,213$14.2K<0.1%+7,934+59.7%AddedHolders
Q3 202513,279$5.83K<0.1%−778,927−98.3%ReducedHolders
Q2 2025792,206$351.7K<0.1%+768,641+3,261.8%AddedHolders
Q1 202523,565$13.3K<0.1%−13,602−36.6%ReducedHolders
Q4 202437,167$78.4K<0.1%+16,445+79.4%AddedHolders
Q3 202420,722$55.7K<0.1%+6,866+49.6%AddedHolders
Q2 202413,856$39.5K<0.1%−26,873−66.0%ReducedHolders
Q1 202440,729$172.7K<0.1%−5,845−12.5%ReducedHolders
Q4 202346,574$249.2K<0.1%+26,303+129.8%AddedHolders
Q3 202320,271$87.2K<0.1%−6,617−24.6%ReducedHolders
Q2 202326,888$147.6K<0.1%+23,370+664.3%AddedHolders
Q1 20233,518$14.8K<0.1%−1,348−27.7%ReducedHolders
Q4 20224,866$13.5K<0.1%+2,077+74.5%AddedHolders
Q3 20222,789$7.00K<0.1%+2,170+350.6%AddedHolders
Q2 2022619$2.00K<0.1%−2,482−80.0%ReducedHolders
Q1 20223,101$19.0K<0.1%−7,614−71.1%ReducedHolders
Q4 202110,715$75.0K<0.1%+7,482+231.4%AddedHolders
Q3 20213,233$23.0K<0.1%+2,878+810.7%AddedHolders
Q2 2021355$3.00K<0.1%−5,278−93.7%ReducedHolders
Q1 20215,633$31.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.